Clinical trial

Early clinical trial results show promise for Alzheimer’s treatment

Patients could be set to benefit from a breakthrough in dementia care after a clinical trial reported promising initial results for a treatment that alters the course of Alzheimer’s disease.

For the research, a team from University College London Hospitals NHS Foundation Trust (UCLH) investigated the efficacy of a treatment known as ALN-APP, a type of gene silencing therapy called RNA interference.

Researchers hope that this type of treatment can inhibit the production of amyloid proteins and therefore lead to the prevention of Alzheimer’s disease.

After enrolling 20 patients with early-onset Alzheimer's disease – the leading cause of dementia in young people – researchers found that single doses of ALN-APP were well tolerated and demonstrated significant and sustained reductions in specific amyloid molecules.

                                                                          Video credit: Canva

Consultant neurologist at UCLH’s national hospital for neurology and neurosurgery, Dr Catherine Mummery, is one of eight investigators worldwide for the trial, and the only one based in the UK.

The news comes shortly after results from the clinical trial studying the treatment, donanemab, were announced at the Alzheimer's Association International Conference, which revealed that the drug was able to delay deterioration in some patients by 35%.

Click here to find out more.

Image credit: iStock

NHE Nov/Dec 2023

NHE Nov/Dec 2023

AI is key in helping dementia patients live independently for longer.

The Nov/Dec 2023 edition of NHE brings you expert comment and analysis on a range of key health sector topics, from digital transformation to navigating post-pandemic challenges.

Videos...

View all videos
National Health Executive Presents

National Health Executive Presents

NHE365 Virtual Events

NHE has created a full calendar of events to address the most important issues that influence the delivery of healthcare services. Over 365 days you'll have the opportunity to hear from a range of highly motivating, informative and inspirational speakers. These speakers will equip you with the knowledge and unique insight to enable you to overcome the challenges that you face.

National Health Executive Podcast

Ep 39.
What makes a good NHS manager? with Anthony Painter, Director of Policy at Chartered Management Institute (CMI)

In episode 39 of the National Health Executive podcast, we were joined by Anthony Painter, who is the director of policy at the Chartered Management Institute (CMI), to discuss all things management within the UK health sector and NHS.
 

During the podcast, Anthony shared some of the recent research CMI conducted in partnership with the Social Market Foundation, which centred around the state of management and leadership within the NHS.

More articles...

View all